GSI (Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg)

Generic Name: emtricitabine/rilpivirine/tenofovir

Pill imprint GSI has been identified as Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg.

Complera is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GSI

Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg GSI
Complera
Generic Name:
emtricitabine/rilpivirine/tenofovir
Imprint:
GSI
Strength:
emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Gilead Sciences, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)